Citations

Showing 10 of 108119 citations.

Teaching Video NeuroImages: MT-TL1 mutation presenting as chronic progressive external ophthalmoplegia
Parsons, Angela, Mehta, Shyamal H. , Acierno, Marie D, Dhamija, Radhika , Parsons, Angela M, Dhamija, Radhika

Mayo Clinic

Neurology | January 22, 2019 | Volume: 92 | Issue: 4 | Pages: No page available

10.1212/wnl.0000000000006817 | PMID 30665919 Get It

Shared Medical and Environmental Risk Factors in Dry Eye Syndrome, Sjogren’s Syndrome, and B-Cell Non-Hodgkin Lymphoma: A Case-Control Study
Ben‐Eli, Hadas , Aframian, Doron J. , Ben‐Chetrit, Eldad , Mevorach, Dror , Kleinstern, Geffen , Paltiel, Ora , Solomon, Abraham

Mayo Clinic

Journal of Immunology Research | January 21, 2019 | Volume: 2019 | Issue: No issue available | Pages: 1-9

10.1155/2019/9060842 | PMID 30805374 Get It

Objectives. To assess whether there are shared exposures associated with Sjogren’s syndrome (SS), dry eye syndrome (DES), and B-cell non-Hodgkin lymphoma (B-NHL), in order to determine whether they are etiologically related. Methods. In a clinic-based case-control study, 702 participants (91 SS, 120 DES, 211 (age and sex frequency-matched) controls, and 280 B-NHL cases) were recruited and interviewed regarding exposures, medical history, and family history. Results. Female predominance was noted in SS (ratio 9.2 : 1). Eye dryness was severest in SS compared to DES and controls (P<0.001). Compared to controls, alcohol consumption was inversely associated with NHL, DES, and SS (odds ratio OR=0.47, 95% confidence interval (CI): 0.31-0.71; OR=0.54, 95% CI: 0.33-0.88; and OR=0.26, 95% CI: 0.14-0.49, respectively), while a previous history of infection requiring hospitalization was positively associated with all three conditions: NHL (OR=1.92; 95% CI: 1.23-2.99), DES (OR=3.29; 95% CI: 1.97-5.47), and SS (OR=4.74; 95% CI: 2.66-8.44). NHL patients were more likely to report first-degree relatives with hematologic cancer, while having first-degree relatives with an autoimmune disease (AID) was associated with SS (OR=5.25; 95% CI: 2.59-10.63) and DES (OR=3.55; 95% CI: 1.83-6.91) compared to controls. Conclusions. Some exposures are associated with all three conditions (such as an inverse association with alcohol consumption and a positive association with serious past infection), while a family history of AID appears to be shared by DES and SS, but not NHL subjects. Shared risk factors for all three conditions indicate possible mutual etiological pathways.
Letter by Sandoval et al Regarding Article, “Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation “High-Sensitivity” Cardiac Troponin Assays to Diagnose Myocardial Infarction”
Sandoval, Yader , Jaffe, Allan S. , Apple, Fred S. , Jaffe, Allan S.

Mayo Clinic

Circulation | January 21, 2019 | Volume: 139 | Issue: 4 | Pages: 562-563

10.1161/circulationaha.118.037452 | PMID 30664372 Get It

Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer
Reichman, Hadar , Itan, Michal, Rozenberg, Perri, Yarmolovski, Tal, Brazowski, Eli, Varol, Chen , Shapira, Shiran , Arber, Nadir , Qimron, Udi , Karo‐Atar, Danielle , Lee, James J. , Munitz, Ariel , Munitz, Ariel , Gluck, Nathan

Mayo Clinic

Cancer Immunology Research | January 21, 2019 | Volume: 7 | Issue: 3 | Pages: 388-400

10.1158/2326-6066.cir-18-0494 | PMID 30665890 Get It

Abstract Immunotherapies targeting T lymphocytes are revolutionizing cancer therapy but only benefit a subset of patients, especially in colorectal cancer. Thus, additional insight into the tumor microenvironment (TME) is required. Eosinophils are bone marrow–derived cells that have been largely studied in the context of allergic diseases and parasite infections. Although tumor-associated eosinophilia has been described in various solid tumors including colorectal cancer, knowledge is still missing regarding eosinophil activities and even the basic question of whether the TME promotes eosinophil recruitment without additional manipulation (e.g., immunotherapy) is unclear. Herein, we report that eosinophils are recruited into developing tumors during induction of inflammation-induced colorectal cancer and in mice with the Apcmin/+ genotype, which develop spontaneous intestinal adenomas. Using adoptive transfer and cytokine neutralization experiments, we demonstrate that the TME supported prolonged eosinophil survival independent of IL5, an eosinophil survival cytokine. Tumor-infiltrating eosinophils consisted of degranulating eosinophils and were essential for tumor rejection independently of CD8+ T cells. Transcriptome and proteomic analysis revealed an IFNγ-linked signature for intratumoral eosinophils that was different from that of macrophages. Our data establish antitumorigenic roles for eosinophils in colorectal cancer. These findings may facilitate the development of pharmacologic treatments that could unleash antitumor responses by eosinophils, especially in colorectal cancer patients displaying eosinophilia.
Faculty Opinions recommendation of AGA institute clinical practice update: endoscopic submucosal dissection in the united states.
Song, Louis M. Wong Kee

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 21, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.734269010.793555033 Get It

Area postrema syndrome in autoimmune GFAP astrocytopathy
Sechi, Elia , Flanagan, E P , Sechi, Elia , Flanagan, Eoin P.

Mayo Clinic

Multiple Sclerosis Journal | January 21, 2019 | Volume: 26 | Issue: 2 | Pages: 255-256

10.1177/1352458519826489 | PMID 30663500 Get It

Identifying patient‐important outcomes in polycystic kidney disease: An international nominal group technique study
Cho, Yeoungjee , Sautenet, Bénédicte , Gutman, Talia , Rangan, Gopala K. , Craig, Jonathan C. , Ong, Albert , Chapman, Arlene B., Coolican, Helen, Kao, Juliana T‐W, Gansevoort, Ron T. , Harris, Tess , Torres, Vicente E. , Pei, York , Ryan, Jessica , Johnson, David W. , Viecelli, Andrea K. , Geneste, Claire, Oh, Yun Kyu , Teixeira‐Pinto, Armando , Logeman, Charlotte , Howell, Martin , Ju, Angela, Manera, Karine , Tong, Allison , Torres, Vicente E , Johnson, David W , Howell, Martin , Ong, Albert C M , Ahn, Curie , Kao, Juliana Tze‐Wah , Perrone, Ronald D. , Kerr, Peter G. , Kim, Hyunsuk , Kim, Yaerim , Cho, Yeoungjee

Mayo Clinic

Nephrology | January 21, 2019 | Volume: 24 | Issue: 12 | Pages: 1214-1224

10.1111/nep.13566 | PMID 30663163 Get It

ABSTRACTAimPatients with autosomal dominant polycystic kidney disease (ADPKD) are at increased risk of premature mortality, morbidities and complications, which severely impair quality of life. However, patient‐centered outcomes are not consistently reported in trials in ADPKD, which can limit shared decision‐making. We aimed to identify outcomes important to patients and caregivers and the reasons for their priorities.MethodsNominal group technique was adopted involving patients with ADPKD and caregivers who were purposively selected from eight centres across Australia, France and the Republic of Korea. Participants identified, ranked and discussed outcomes for trials in ADPKD. We calculated an importance score (0–1) for each outcome and conducted thematic analyses.ResultsAcross 17 groups, 154 participants (121 patients, 33 caregivers) aged 19 to 78 (mean 54.5 years) identified 55 outcomes. The 10 highest ranked outcomes were: kidney function (importance score 0.36), end‐stage kidney disease (0.32), survival (0.21), cyst size/growth (0.20), cyst pain/bleeding (0.18), blood pressure (0.17), ability to work (0.16), cerebral aneurysm/stroke (0.14), mobility/physical function (0.12), and fatigue (0.12). Three themes were identified: threatening semblance of normality, inability to control and making sense of diverse risks.ConclusionFor patients with ADPKD and their caregivers, kidney function, delayed progression to end‐stage kidney disease and survival were the highest priorities, and were focused on achieving normality, and maintaining control over health and lifestyle. Implementing these patient‐important outcomes may improve the meaning and relevance of trials to inform clinical care in ADPKD.
Clinical features of scleromyxoedema in an Afro-Caribbean man
Ufodiama, Chiedu , Tynes, Gregory, Unwala, Rashmi, Ufodiama, Chiedu E

Mayo Clinic

BMJ Case Reports | January 21, 2019 | Volume: 12 | Issue: 1 | Pages: e227588

10.1136/bcr-2018-227588 | PMID 30665930 Get It

Editorial: the role of vitamin D in autoimmune hepatitis—authors' reply
Ebadi, Maryam , Czaja, Albert J. , Montaño‐Loza, Aldo J. , Montano-Loza, Aldo J

Mayo Clinic

Alimentary Pharmacology & Therapeutics | January 21, 2019 | Volume: 49 | Issue: 3 | Pages: 343-344

10.1111/apt.15091 | PMID 30663106 Get It

Linked ContentThis article is linked to Ebadi et al and Imga and Efe papers. To view these articles, visit https://doi.org/10.1111/apt.15029 and https://doi.org/10.1111/apt.15075.
Association Between Alcohol Use and Female Sexual Dysfunction From the Data Registry on Experiences of Aging, Menopause, and Sexuality (DREAMS)
Kling, Juliana M. , Sidhu, Kimran, Rullo, Jordan , Mara, Kristin C. , Hilsaca, Karla S. Frohmader, Kapoor, Ekta , Frohmader Hilsaca, Karla S, Mara, Kristin C , Kling, Juliana M , Kapoor, Ekta , Faubion, Stephanie S.

Mayo Clinic

Sexual Medicine | January 21, 2019 | Volume: 7 | Issue: 2 | Pages: 162-168

10.1016/j.esxm.2018.11.009 | PMID 30674443 Get It

Abstract Introduction Sexual dysfunction is a common problem in women and the nature of its association with alcohol use remains unclear. Aim To explore the association between alcohol use and female sexual dysfunction (FSD). Methods Associations between self-reported drinking and sexual function were evaluated in 2,253 women presenting for consultation to a women’s health specialty clinic. A short version of the Alcohol Use Disorders Identification Test (AUDIT-C) was used to evaluate alcohol use. Women with an AUDIT-C ≥3 were considered at risk for hazardous drinking. Multivariable regression, controlling for depression, anxiety, and abuse (childhood and recent), was used to assess the association between alcohol consumption and FSD (defined as a Female Sexual Function Index [FSFI] ≤26.55 and Female Sexual Distress Scale [FSDS] ≥11) in sexually active women. Main Outcome Measure The main study outcome measure was the presence of FSD as defined by a score ≤26.55 on the FSFI and ≥11 on the FSDS. Results 57% of the 1,649 sexually active women were classified as having FSD; 80% reported any alcohol use and 38% reported drinking patterns with the potential to be hazardous. The women at risk for hazardous drinking had significantly higher FSFI domain scores indicating better sexual function (P ≤ .001). However, in multivariable analyses, there was no significant difference in the rates of FSD across alcohol use categories in women. Conclusion In women presenting for consultation to a women’s health specialty clinic, an association between alcohol use and FSFI scores was seen, in which greater risk of hazardous drinking was associated with better sexual function scores. However, when sexual distress was included to define sexual dysfunction, those with FSD were not at higher risk of hazardous drinking. Given the complex nature of FSD, additional study is needed to further clarify these relationships.